IlluminOss Medical receives conditional FDA approval for clinical trial

EAST PROVIDENCE – IlluminOss Medical has received conditional approval from the federal Food and Drug Administration to conduct a clinical trial for treatments of impending and pathologic fractures in the humerus due to metastatic carcinoma. IlluminOss Medical, a privately held, commercial medical device company that focuses on minimally invasive orthopedic fracture repair, said that it…
To read the full story, Subscribe or
Subscribe to PBN
- Advertisement -